mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.26 |
0.4 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.4 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |